Financial Associated Press, Dec. 7 (Xinhua) -- Evergrande motor rose by more than 8% in the short term and is now reported at HK $3.3.
Financial Associated Press, Dec. 7 (Xinhua) -- Evergrande motor rose by more than 8% in the short term and is now reported at HK $3.3.
This text is a result of machine translation.
Related companies：
Briefing Mar 10, 2022 03:38 PM
· Automotive
The business scope of Evergrande automobile new company includes online car Hailing service
In-depth
Technology
Exploring Seven Forms of Intelligent Manufacturing
The pandemic has brought several challenges for manufacturers, including growing skills gaps, employee shortages and erratic supply-chain disruptions. Manufacturers need visible and intelligent manufacturing processes to upgrade the product design, production and management process to face the dynamics and fluctuations of the global market.
Nov 17, 2022 10:55 PM
Briefing Jan 13, 2022 03:19 PM
· Automotive
Haitong strategy: domestic infrastructure policy is expected to be strengthened this year
Chinese medicine stocks led the decline in the opening, and Huasen pharmaceutical once hit the limit
Nov 10, 2022 02:39 PM
Nov 08, 2022 08:32 AM
Nov 05, 2022 03:50 PM
Research
AutomotiveFinancing and Investment Activities in China's Mobility Industry From 2012 to 2022
Oct 07, 2022 09:33 AM
Survey: if the climate situation is not improved, six major cities in the world may sink before 2030
Briefing Oct 07, 2021 06:33 PM
· Automotive
Zhongyu group: investing in Evergrande notes and Evergrande auto shares will produce significant losses
Briefing Sep 29, 2021 10:11 AM
· Technology
"Paixun intelligence" announced the completion of tens of millions of yuan pre-A + round of financing
Briefing Sep 26, 2021 08:00 PM
· Automotive
Evergrande Motor announced on the Hong Kong stock exchange that the proposed issuance of RMB shares will not continue.
Briefing Sep 16, 2021 10:31 AM
· Automotive
Chevron CEO: natural gas and oil prices will be quite strong in the foreseeable future
See more
Read next
Insight
In-depth
Insight
In-depth
Healthcare
Immunotherapy in China: A Rising Star in the Field of Cancer Treatment
Nov 24, 2022 06:29 PM
Insight
In-depth
Healthcare
Challenges and Opportunities Possessed by Digital Therapeutics Industry
Nov 23, 2022 03:23 PM
Insight
In-depth